SJS Investment Consulting’s ADC Therapeutics ADCT Stock Holding History

SJS Investment Consulting’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35	Buy	+32	New	+$93	﹤0.01%	2785

Other funds holding ADCT

Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return

Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Saxony Capital Management St. Louis, Missouri $218M AUM 24.57% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SJS Investment Consulting's ADCT Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in ADC Therapeutics (ADCT) in Q2 2026: 32 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #2785 among its holdings.

16 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

SJS Investment Consulting held 32 shares of ADC Therapeutics worth $35 as of Q2 2026.
ADC Therapeutics was a new SJS Investment Consulting position in Q2 2026.
ADC Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2785 holding.
16 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.